Question Bank › Counterparties stepping up before the numbers do

Counterparties stepping up before the numbers do

Counterparties stepping up before the numbers do: escalating committed demand the reported results don't yet show

Calls Tested
492
Answered YES
16
Hit Rate
3.3%
rare by design

Ares Capital Corporation (ARCC) — this company's answers

NO on the Q1 2022 call 2022-04-26 B
The model's full reasoning — Q1 2022 call → NOWe need answer YES/NO. Need analyze transcript. Need determine if management describes counterparties paying company currently stepping up commitment beyond prior level, and results don't yet reflect because contribution only beginning/mostly ahead. We need parse. Company is BDC, counterparties are borrowers? Paying counterparties? Management discusses investment activity, portfolio, Ivy Hill, Annaly acquisition. Need see if there is "customers/clients" stepping up. Maybe "borrowers" seeking capital? They mention private equity dry powder, demand for private credit solutions. But is that current escalation? They say "we expect continued volatility... will lead to increased demand" future. Not current. Also "two-thirds of commitments to incumbent borrowers" but not escalation. Annaly acquisition: Ares management acquired portfolio, half funded by ARCC and Ivy Hill. This is a portfolio acquisition, not paying counterparties stepping up. It is a purchase of loans, not customers increasing commitment. Also Ivy Hill dividend increased, but that's internal subsidiary. Question asks: On this call, does management describe that counterparties who pay the company — customers, clients, partners, distributors, payers, or program sponsors — are CURRENTLY STEPPING UP their commitment to the company in a way that goes clearly beyond their prior level of business, AND does management convey that the reported results do not yet meaningfully reflect that step-up, because its contribution is only beginning and mostly still ahead? Need identify if any such. Management talks about "private equity dry powder" and "larger companies seeing value in seeking private capital solutions" and "expect continued volatility... will lead to increased demand from issuers for private credit solutions" - future expectation, not current. Also "we feel good about positioning" but not current step-up. Maybe "Ivy Hill" dividend increase? No. Maybe "Annaly portfolio acquisition" - counterparties? No, it's buying loans. The loans are to companies, but not "paying counterparties stepping up" - it's acquiring existing portfolio. Management says "we expect revenue growth from these investments may ultimately support additional dividends from Ivy Hill to ARCC after transaction closes" - future, not current.

← Back to the full ARCC analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that the counterparties who pay the company — customers, clients, partners, distributors, payers, or program sponsors — are CURRENTLY STEPPING UP their commitment to the company in a way that goes clearly beyond their prior level of business, AND does management convey that the reported results do not yet meaningfully reflect that step-up, because its contribution is only beginning and mostly still ahead? Answer YES when management's own words convey BOTH halves as one coherent, present-tense story, in whatever form fits the business: (1) A REAL ESCALATION BY PAYING COUNTERPARTIES, ALREADY HAPPENING OR ALREADY COMMITTED. Management describes counterparties moving to a distinctly higher level of engagement than they had before — not merely strong demand in the usual pattern. This may take whatever form fits the industry, for example: customers who started small now committing to substantially larger volumes, broader deployments, more sites, or wider scope; a counterparty moving a relationship from an initial phase into a much bigger committed phase; orders, bookings, or committed work arriving at a scale or pace beyond what the company had been receiving; buyers committing earlier, longer, or bigger than this business has been used to; or new business already won whose delivery ramps ahead. What matters is that the escalation is described as actually occurring or actually committed now — real orders, signed expansions, deliveries beginning, ramps underway — grounded in the behavior of identifiable paying counterparties, not in pipeline, interest, market size, or management's own hopes. (2) THE NUMBERS LAG THE ESCALATION, AND MANAGEMENT SAYS SO. Management conveys, directly or plainly in substance, that the results just reported still mostly reflect the business before this step-up — for example, the larger commitments have only begun converting into revenue, the ramp is early with most delivery ahead, or the company is now preparing, hiring, or building to serve committed business that has not yet flowed through the reported period — so today's numbers understate the business the counterparties have already committed to. Answer NO if the call describes only strong demand, growth, or a good quarter in the company's ordinary rhythm, without counterparties visibly moving to a higher level of commitment than before. NO if the step-up is only hoped for, in negotiation, in pipeline, or dependent on decisions, approvals, or financing not yet obtained. NO if the escalation is a single routine order or renewal of normal size for this business. NO if the increased activity is attributed mainly to a temporary spike, catch-up, pull-forward, or one-time event that management expects to fade. NO if the escalated business is already fully reflected in the reported results with nothing meaningful still to convert. NO if management is chiefly explaining delays, cancellations, or problems with a previously described ramp. NO if the idea appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
OEC Orion Engineered Carbons S.A. Q4 2022 2023-02-17 B+
EVGO EVgo, Inc. Q2 2022 2022-08-09 C+
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
OOMA Ooma, Inc. Q3 2022 2021-12-02 B+
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
KOP Koppers Holdings Inc. Q2 2018 2018-08-12 C+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
ILMN Illumina, Inc. Q1 2018 2018-04-24 A
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

How the model reasoned

KOP · Q2 2018 → YESThe question is: Does management describe that counterparties (customers etc.) are CURRENTLY STEPPING UP their commitment beyond prior levels, AND that reported results do not yet meaningfully reflect...**NO** The transcript does not describe any counterparties (customers, clients, partners, etc.) currently stepping up their commitment to a distinctly higher level of engagement beyond prior patterns in a way that is already occurring or committed now, with the reported results lagging because most of the benefit is still ahead. The closest item is the major box store converting its ground-contact treated wood program to Koppers’ patented MicroPro technology, planned for late fall with “little effect on the balance of 2018” and a “nice boost heading into 2019.
SCPH · Q3 2023 → YESThe question is: Does management describe that counterparties who pay the company are CURRENTLY STEPPING UP their commitment beyond prior levels, AND that the reported results do not yet meaningfully ...YES The transcript shows management describing a clear escalation in payer commitments: a new unrestricted-access agreement with the largest closed IDN (over 8 million lives, fixed copay) and preferred formulary status with a major government retiree payer (adding 1.1 million lives). They explicitly note that direct IDN purchases were not meaningful in Q3 but will be “a meaningful part of our business” moving forward, especially in 2024, and that the new payer decisions “could positively impact FUROSCIX co-pays as early as the fourth quarter.
GFS · Q3 2021 → YESThe question is: Does management describe that counterparties (customers) are CURRENTLY STEPPING UP their commitment beyond prior levels, AND that the reported results do not yet meaningfully reflect ...**YES** Management describes counterparties (customers) stepping up their commitment through new and expanded long-term agreements (LTAs) and prepayments/access fees, which have grown since the roadshow (from ~$2.5B to north of $3B, with additional $500M+ added post-roadshow) and now exceed $20B in forward revenues. This is framed as real escalation in committed business, with customers signing more agreements and prepaying for future capacity. The reported Q3 results ($1.7B revenue, $0.07 adjusted EPS) and Q4 guidance ($1.

More from the question bank

Escape velocity out of a small baseCash cost of the waitPromise already turning into factMomentum handoff to a young engineCustomers coming back on their ownScheduled future in administrationAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.